Development of ctDNA for MRD detection in breast cancer

被引：0
|
作者：
Ozaki, Y. [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Adv Med Dev, Dept Breast Med Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.691
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY26-2
引用
收藏
页码：S1296 / S1296
页数：1
相关论文
共 50 条
  • [41] Characterization of breast cancer ctDNA with Omi-Seq
    Wang, Yinghao
    Guan, Yaoyao
    Xiang, Jingjing
    Kong, Lingguo
    Lin, Lizhi
    Webb, Judy
    Tong, Yunguang
    Wang, Ouchen
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Exploring the role of ctDNA in triple negative breast cancer
    den Brok, W. D.
    Kong, E.
    Bates, C.
    Aguirre-Hernandez, R.
    Miller, R. R.
    Lum, A.
    Wan, A.
    Shah, S.
    Aparicio, S.
    Gelmon, K. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [43] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Bagegni, Nusayba A.
    Ademuyiwa, Foluso O.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (04) : 356 - 363
  • [44] DEVELOPMENT OF AN IMAGING SYSTEM FOR BREAST CANCER DETECTION
    Singh, Rakesh
    Singh, Soni
    Singh, Vineet
    Singh, Dharmendra
    Gupta, Manoj
    2022 IEEE MICROWAVES, ANTENNAS, AND PROPAGATION CONFERENCE, MAPCON, 2022, : 1975 - 1978
  • [45] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Nusayba A. Bagegni
    Foluso O. Ademuyiwa
    Current Breast Cancer Reports, 2023, 15 : 356 - 363
  • [46] ctDNA/MRD Testing for Colon Cancer: A Work in Progressor Ready for Prime-Time Standard of Care?
    Caughey, Bennett A.
    Parikh, Aparna R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (10):
  • [47] Association between copy number aberration and ctDNA MRD in colorectal cancer: CIRCULATE-Japan GALAXY
    Harima, T.
    Yamashita, R.
    Nakamura, Y.
    Sakai, S.
    Nomura, R.
    Saori, M.
    Kotani, D.
    Taniguchi, H.
    Watanabe, J.
    Takemasa, I.
    Kato, T.
    Oki, E.
    Yoshizumi, T.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S458 - S458
  • [48] Discerning the impact of ctDNA detection on patient decision-making in early-stage breast cancer
    Ballinger, Tarah J.
    Smith, Mary Lou
    Railey, Elda
    Zimet, Greg
    Schneider, Bryan P.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [49] Immunomagnetic cell selection for removal and enhanced detection of MRD from PBSC harvest in breast cancer patients
    Hempel, D
    Oruzio, D
    Brockmeyer, C
    Wochner, M
    Behr, W
    Ehnle, S
    Schlimok, G
    BLOOD, 1996, 88 (10) : 991 - 991
  • [50] Comparison of tumor-informed and tumor-naive sequencing assays for ctDNA detection in breast cancer
    Santonja, Angela
    Cooper, Wendy N.
    Eldridge, Matthew D.
    Edwards, Paul A. W.
    Morris, James A.
    Edwards, Abigail R.
    Zhao, Hui
    Heider, Katrin
    Couturier, Dominique-Laurent
    Vijayaraghavan, Aadhitthya
    Mennea, Paulius
    Ditter, Emma-Jane
    Smith, Christopher G.
    Boursnell, Chris
    Garcia, Raquel Manzano
    Rueda, Oscar M.
    Beddowes, Emma
    Biggs, Heather
    Sammut, Stephen-John
    Rosenfeld, Nitzan
    Caldas, Carlos
    Abraham, Jean E.
    Gale, Davina
    EMBO MOLECULAR MEDICINE, 2023, 15 (06)
12345